Skip to content

Clinical trials

Phase 1 Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1 Country / region: United States Clear all

338 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20017
20023
20033
20047
20059
200615
20078
200811
20099
201010
20118
201213
201310
201411
201517
201618
201711
201816
201919
202025
202115
202218
202320
202416
20259
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed185
Terminated72
Recruiting35
Active, not recruiting34
Suspended4
Unknown status3
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)28
Novartis Pharmaceuticals12
Pfizer12
M.D. Anderson Cancer Center11
Bristol-Myers Squibb8
Celldex Therapeutics7
GlaxoSmithKline7
Memorial Sloan Kettering Cancer Center7
City of Hope Medical Center6
Incyte Corporation6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell338
Carcinoma, Non-Small-Cell Lung124
Melanoma114
Kidney Neoplasms77
Colorectal Neoplasms69
Squamous Cell Carcinoma of Head and Neck63
Breast Neoplasms62
Ovarian Neoplasms58
Stomach Neoplasms53
Neoplasms51

Trials

Showing 1 to 25 of 338. Each trial links to its page on Pharma Observatory.

238 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.